We evaluated the effectiveness of mizoribine, a newly developed immunosuppressive agent, as an adjuvant therapy in the treatment of both pemphigus vulgaris and pemphigus foliaceus. Eleven pemphigus patients (eight pemphigus vulgaris and three pemphigus foliaceus) received the combination therapy of…
- Inicio
- Sobre nosotros
- Viviendo con P/P
- Investigación
- Involucrarse
- Noticias & Info
- Discussion Forums
